Amoéba Publishes 2025 Universal Registration Document

Amoéba, a greentech company based in Chassieu, France, has announced the publication of its 2025 Universal Registration Document. Filed with the French Financial Markets Authority, this document includes the company's annual financial report, corporate governance details, and reports from statutory auditors. This comprehensive document is accessible on Amoéba's website for interested parties.

The company's pioneering use of amoebae in microbiological solutions targets plant protection and cosmetics. Following regulatory progress, its biocontrol product for plant protection has gained approval in the United States and is pending in Europe. The cosmetic ingredient is globally marketable, although it awaits approval in China. Amoéba's innovative approach is protected by multiple patents, setting it apart in the industrial use of Willaertia amoeba.